% Generated by roxygen2: do not edit by hand
% Please edit documentation in R/data.R
\docType{data}
\name{lb_neuro}
\alias{lb_neuro}
\title{Laboratory Test Results for Nervous System Dataset}
\format{
A data frame with 23 columns:
\describe{
\item{STUDYID}{Study Identifier}
\item{DOMAIN}{Domain Abbreviation}
\item{USUBJID}{Unique Subject Identifier}
\item{LBSEQ}{Sequence Number}
\item{LBTESTCD}{Lab Test or Examination Short Name}
\item{LBTEST}{Lab Test or Examination Name}
\item{LBCAT}{Category for Lab Test}
\item{LBORRES}{Result or Finding in Original Units}
\item{LBORRESU}{Original Units}
\item{LBORNRLO}{Reference Range Lower Limit in Orig Unit}
\item{LBORNRHI}{Reference Range Upper Limit in Orig Unit}
\item{LBSTRESC}{Character Result/Finding in Std Format}
\item{LBSTRESN}{Numeric Result/Finding in Standard Units}
\item{LBSTRESU}{Standard Units}
\item{LBSTNRLO}{Reference Range Lower Limit-Std Units}
\item{LBSTNRHI}{Reference Range Upper Limit-Std Units}
\item{LBNRIND}{Reference Range Indicator}
\item{LBBLFL}{Baseline Flag}
\item{VISITNUM}{Visit Number}
\item{VISIT}{Visit Name}
\item{VISITDY}{Planned Study Day of Visit}
\item{LBDTC}{Date/Time of Specimen Collection}
\item{LBDY}{Study Day of Specimen Collection}
}
}
\source{
Constructed using \code{dm_neuro}, \code{nv_neuro}, and \code{adsl_neuro} from \code{{admiralneuro}} package,
along with \code{ex} from \code{{pharmaversesdtm}} package
}
\usage{
lb_neuro
}
\description{
A SDTM LB domain dataset containing laboratory test results for Alzheimer's Disease studies,
specifically Alpha-synuclein Seed Amplification Assay (SAA) results from cerebrospinal fluid (CSF) samples.
The dataset includes baseline assessments with positive rates varying by treatment group.
}
\details{
The dataset contains Alpha-synuclein Seed Amplification Assay (ASYNASAA) results
categorized as "Positive" or "Negative". Results are generated with treatment-specific
positive rates: 30\% for placebo/control group across all visits, and 30\% at baseline
for treatment group. The dataset is structured to support analysis of biomarker status
in Alzheimer's Disease clinical trials.
}
\keyword{datasets}
